NAD+ in cellular metabolism research

Research overview

NAD+ is a redox cofactor involved in electron transfer reactions and a substrate for sirtuin and PARP enzyme families. It is a standard reagent in enzymology.

Molecular characteristics

A dinucleotide of nicotinamide mononucleotide and adenosine monophosphate joined by a pyrophosphate bridge; hygroscopic in the lyophilised state.

Areas examined in published research

Redox balance, sirtuin activity, DNA-repair enzymology, and mitochondrial function.

Study designs and model systems

Enzyme assays, cultured cells, and rodent models of NAD precursor supplementation.

In vitro evidence

Extensive and well-established use as an enzymatic cofactor in defined assay systems.

Animal-model evidence

Rodent studies of NAD-boosting molecules report metabolic changes with variable effect sizes.

Human clinical research

Human studies of NAD precursors are early-stage, small, and short in duration.

Limitations

Much of the interest in NAD biology derives from rodent work; human evidence remains preliminary.

Regulatory status

Supplied as a research reagent for laboratory use only. Not a supplement, food, or drug.

References

• Rajman L, Chwalek K, Sinclair DA (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism.

  Review · In vivo rodent studies and early human trials · source pending verification

  Review of in vivo evidence for NAD-precursor and NAD-boosting molecules.

  Limitations: Human evidence at time of publication was early-stage and limited in size and duration.

Referenced materials

• NAD+